Peripheral Neuropathy Trial, Recruiting NCT06511674 Sponsor: University Hospital, Clermont-Ferrand Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06511674
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with cancer:

  • Adults aged 18 or over
  • People diagnosed with breast, gynaecological, colorectal, or lung cancer who are due to undergo one or more cancer treatments (such as chemotherapy, surgery, hormone therapy, radiotherapy, or targeted therapy)
  • People who are able to understand and follow the requirements of the study
  • People who agree to give verbal consent to take part
  • People who are enrolled in the French Social Security system

For healthy volunteers:

  • Adults aged 18 or over
  • People who have not taken any medications in the 7 days before joining, particularly no painkillers — or whose medications the trial site considers compatible with the study
  • People with no history of cancer
  • People considered to be in good health by the trial site
  • People who are able to understand and follow the requirements of the study
  • People who agree to give verbal consent to take part
  • People who are enrolled in the French Social Security system

Who may not be able to join:

For people with cancer:

  • People who have had a previous cancer diagnosis or received previous cancer treatments (such as surgery, chemotherapy, radiotherapy, hormone therapy, or targeted therapy)
  • People with a history of, or current, primary brain tumours (such as glioblastoma, meningioma, or neurofibroma)
  • People with a history of neurological conditions (such as Parkinson's disease, Alzheimer's disease, dementia, epilepsy, or moderate to severe head injury)
  • People whose medical or surgical history the trial site considers incompatible with the study
  • People who are unable to fully understand or follow the study requirements
  • Women who are pregnant or breastfeeding
  • People who are under a legal protection order

For healthy volunteers:

  • People whose medical or surgical history the trial site considers incompatible with the study
  • People who are unable to fully understand or follow the study requirements
  • Women who are pregnant or breastfeeding
  • People currently taking part in another clinical trial, within a post-trial exclusion period, or who have received more than €4,500 in trial compensation over the past 12 months
  • People who are under a legal protection order

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 473754963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 October 2024
Est. completion
31 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

CANoPy score (Z-score); CANoPy score (Z-score); CANoPy score (Z-score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov